1-11 of 11
Christina Sauerland
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Aldehyde Dehydrogenase 2 ( ALDH2 ) Expression Predicts a Poor Prognosis in Acute Myeloid Leukemia

Linus Angenendt, Eike Bormann, Jan-Henrik Mikesch, Tobias Herold, Klaus H. Metzeler, MD, Stefan K. Bohlander, MD, Dennis Görlich, Maria Francisca Arteaga, Bernhard J. Wörmann, Georg Lenz, Wolfgang Hiddemann, Karsten Spiekermann, Utz Krug, Christina Sauerland, Wolfgang E. Berdel, Christoph Schliemann
Journal: Blood
Blood (2017) 130 (Supplement 1): 1386.
https://doi.org/10.1182/blood.V130.Suppl_1.1386.1386
Published: 2017
Journal Articles

Comparison of FLT3-ITD Detection By High-Throughput Amplicon Sequencing to Routine Diagnostics - a Retrospective Analysis of AMLCG Study Patients

Katrin Reiter, MSc, Max Hubmann, MD, Egor Harin, Sebastian Vosberg, Kathrin Bräundl, Bianka Ksienzyk, Stephanie Schneider, PhD, Annika Maria Dufour, PhD, Evelyn Zellmeier, Stefan K. Bohlander, MD, Christina Sauerland, Dipl.-Math, Wolfgang E Berdel, MD, Bernhard J Wörmann, MD, Thomas Büchner, MD, Jan Braess, MD, Wolfgang Hiddemann, MD, Karsten Spiekermann, MD, Philipp A. Greif, MD
Journal: Blood
Blood (2016) 128 (22): 1682.
https://doi.org/10.1182/blood.V128.22.1682.1682
Published: 2016
Journal Articles

PS29MRC - a Novel Predictive Score for Response to Therapy in Acute Myeloid Leukemia

Tobias Herold, MD, Vindi Jurinovic, Klaus H. Metzeler, MD, Aarif Batcha, Stefan Bamopoulos, Maja Rothenberg-Thurley, PhD, Bianka Ksienzyk, Luise Hartmann, MSc, Philipp Greif, Julia Phillippou-Massier, Stefan Krebs, Helmut Blum, Susanne Amler, Stephanie Schneider, PhD, Christina Sauerland, Dipl.-Math, Dennis Görlich, Thomas Büchner, Wolfgang E Berdel, MD, Bernhard J Wörmann, MD, Marion Subklewe, MD, Michael Fiegl, MD, Stefan K. Bohlander, MD, Jan Braess, Wolfgang Hiddemann, MD, PhD, Ulrich Mansmann, PhD, Karsten Spiekermann, MD
Journal: Blood
Blood (2016) 128 (22): 1209.
https://doi.org/10.1182/blood.V128.22.1209.1209
Published: 2016
Journal Articles

Comparison of Treatment Strategies in Patients over 60 Years with AML: Final Analysis of a Prospective Randomized German AML Intergroup Study

Dietger Niederwieser, MD, Verena Sophia Hoffmann, Dr., Markus Pfirrmann, PhD, Haifa Kathrin Al-Ali, MD, Sebastian Schwind, MD, Vladan Vucinic, MD, Rainer Krahl, PhD, Christoph Kahl, Hans-Heinrich Wolf, MD, Ute Kreibich, Prof., Detlef Hähling, Ute Hegenbart, MD, Carsten Hirt, Norma Peter, MD, Axel Florschuetz, Kolja Reifenrath, Antje Schulze, Niklas Zojer, MD, Sebastian Scholl, Christian Junghanss, MD, Wolfram Pönisch, Simone Heyn, MD, Herbert G. Sayer, Andreas Hochhaus, MD, Thomas Heinicke, MD, Thomas Fischer, MD, Alwin Krämer, MD, Peter Dreger, MD, Georg Maschmeyer, MD, Utz Krug, Maria Christina Sauerland, MSc, Achim Heinecke, Rüdiger Hehlmann, MD, Eva Lengfelder, MD, Wolfgang Hiddemann, MD, Hubert Serve, MD, Carsten Müller-Tidow, Wolfgang E Berdel, MD, Thomas Büchner
Journal: Blood
Blood (2016) 128 (22): 1066.
https://doi.org/10.1182/blood.V128.22.1066.1066
Published: 2016
Journal Articles

High Expression of ARMCX1 Predicts Poor Survival in Intensively Treated Older Acute Myeloid Leukemia Patients (≥ 60 years)

Jan-Henrik Mikesch, MD, Christina Sauerland, Dipl.-Math, Tobias Herold, MD, Dennis Görlich, Eike Bormann, Wolfgang Hartmann, MD, Christoph Schliemann, MD, Bernhard J Wörmann, MD, Wolfgang Hiddemann, Karsten Spiekermann, MD, Matthias Stelljes, Utz Krug, MD, Carsten Muller-Tidow, MD, Thomas Büchner, MD, Wolfgang E Berdel, MD, Maria Francisca Arteaga, PhD
Journal: Blood
Blood (2016) 128 (22): 2840.
https://doi.org/10.1182/blood.V128.22.2840.2840
Published: 2016
Journal Articles

Higher Incidence of Secondary AML and Adverse Molecular Markers, Together with Lower CR and Higher AML Related Death Rates in Elderly Compared to Younger Patients: Results from 2435 Patients Included in the Two German AML Intergroup Studies

Dietger Niederwieser, MD, Verena Sophia Hoffmann, Dr., Utz Krug, MD, Rainer Krahl, PhD, Christina Sauerland, Dipl.-Math, Karsten Spiekermann, MD, Stefan K. Bohlander, MD, Ute Hegenbart, MD, Wolfram Poenisch, MD, Vladan Vucinic, MD, Michael Cross, PhD, Nadja Jaekel, MD, Markus Pfirrmann, Antje Schulze, Alwin Kraemer, MD, Georg Maschmeyer, MD, Christian Junghanss, MD, Sebastian Scholl, Christian Jakob, MD, Thomas Heinicke, MD, Detlev Haehling, Norma Peter, MD, Ute Kreibich, Prof., Christoph Busemann, MD, Haifa Kathrin Al-Ali, MD, Ahmet H. Elmaagacli, MD PhD, B Opitz, Hans-Heinrich Wolf, MD, Wolfgang Hiddemann, MD, Wolfgang E Berdel, MD, Thomas Buechner
Journal: Blood
Blood (2015) 126 (23): 2517.
https://doi.org/10.1182/blood.V126.23.2517.2517
Published: 2015
Journal Articles

Front Line Treatment of Elderly Patients with Acute Promyelocytic Leukemia: Long-Term Results of the German AML Cooperative Group

Eva Lengfelder, MD, Benjamin Hanfstein, MD, Claudia Haferlach, Jan Braess, MD, Utz Krug, MD, Karsten Spiekermann, MD, Torsten Haferlach, Karl-Anton Kreuzer, Hubert Serve, MD, Heinz A. Horst, MD, Susanne Schnittger, Philipp Erben, Bernhard J Woermann, Wolfgang E. Berdel, Maria-Christina Sauerland, Achim Heinecke, Wolf-Karsten Hofmann, Rüdiger Hehlmann, Wolfgang Hiddemann, MD, Thomas Buchner, MD
Journal: Blood
Blood (2011) 118 (21): 425.
https://doi.org/10.1182/blood.V118.21.425.425
Published: 2011
Journal Articles

Dose-dense induction with sequential high-dose cytarabine and mitoxantone (S-HAM) and pegfilgrastim results in a high efficacy and a short duration of critical neutropenia in de novo acute myeloid leukemia: a pilot study of the AMLCG

Clinical Trials & Observations
Jan Braess, Karsten Spiekermann, Peter Staib, Andreas Grüneisen, Bernhard Wörmann, Wolf-Dieter Ludwig, Hubert Serve, Albrecht Reichle, Rudolf Peceny, Daniel Oruzio, Christoph Schmid, Xaver Schiel, Marcus Hentrich, Christina Sauerland, Michael Unterhalt, Michael Fiegl, Wolfgang Kern, Christian Buske, Stefan Bohlander, Achim Heinecke, Herrad Baurmann, Dietrich W. Beelen, Wolfgang E. Berdel, Thomas Büchner, Wolfgang Hiddemann
Journal: Blood
Blood (2009) 113 (17): 3903–3910.
https://doi.org/10.1182/blood-2008-07-162842
Published: 2009
Journal Articles

Pooled Data Analysis of Acute Myeloid Leukemia Patients <= 60 Years with Trisomy 8 Treated within the Studies of the German Acute Myeloid Leukemia Intergroup.

Markus Andreas Schaich, MD, Silke Soucek, Hartmut Döhner, MD, Gerhard Ehninger, MD, Arnold Ganser, MD, Gerhard Heil, MD, Rainer Krahl, MD, Jürgen Krauter, MD, Dietger W. Niederwieser, MD, Christina Sauerland, Thomas Büchner, MD, Richard F. Schlenk, MD
Journal: Blood
Blood (2005) 106 (11): 2374.
https://doi.org/10.1182/blood.V106.11.2374.2374
Published: 2005
Journal Articles

Allogeneic Transplantation from an HLA-Matched Family Donor in First Complete Remission of Acute Myeloid Leukemia Had an Adverse Impact on Quality of Life in Patients Followed for at Least Five Years after Treatment: A Survey of the German AML Intergroup on 525 Patients.

Dorle Messerer, PhD, Jutta Engel, MD, Jörg Hasford, PhD, Markus Schaich, MD, Silke Soucek, Gerhard Ehninger, MD, Christina Sauerland, PhD, Thomas Büchner, MD, Dietger W. Niederwieser, MD, Rainer Krahl, MD, Jürgen Krauter, MD, Irina Schäfer, Arnold Ganser, MD, Claire Schleich, Hartmut Döhner, MD, Richard F. Schlenk, MD
Journal: Blood
Blood (2005) 106 (11): 747.
https://doi.org/10.1182/blood.V106.11.747.747
Published: 2005
Journal Articles

Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial

Clinical Trials & Observations
Wolfgang Kern, Torsten Haferlach, Claudia Schoch, Helmut Löffler, Winfried Gassmann, Achim Heinecke, Maria Christina Sauerland, Wolfgang Berdel, Thomas Büchner, Wolfgang Hiddemann
Journal: Blood
Blood (2003) 101 (1): 64–70.
https://doi.org/10.1182/blood-2002-02-0532
Published: 2003